Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
Caicun Zhou(Tongji University), Gongyan Chen(Harbin Medical University), Yunchao Huang(Kunming Medical University), Jianying Zhou(First Affiliated Hospital Zhejiang University), Lizhu Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Jifeng Feng(Jiangsu Cancer Hospital), Zhehai Wang(Shandong Tumor Hospital), Yongqian Shu(Jiangsu Province Hospital), Jianhua Shi, Yi Hu(Chinese People's Liberation Army), Qiming Wang(Henan Cancer Hospital), Ying Cheng(Jilin Province Tumor Hospital), Fengying Wu(Tongji University), Jianhua Chen(Hunan Cancer Hospital), Xiaoyan Lin(Fujian Medical University), Yongsheng Wang(Sichuan University), Jianan Huang, Jiuwei Cui(First Bethune Hospital of Jilin University), Lejie Cao(University of Science and Technology of China), Yunpeng Liu(First Hospital of China Medical University), Yiping Zhang(Zhejiang Cancer Hospital), Yueyin Pan(University of Science and Technology of China), Jun Zhao(Peking University), Liping Wang(First Affiliated Hospital of Zhengzhou University), Jianhua Chang(Fudan University Shanghai Cancer Center), Qun Chen(Fuzhou Pulmonary Hospital of Fujian), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), Wei Zhang(Nanchang University), Yun Fan(Zhejiang Cancer Hospital), Zhiyong He(Fujian Provincial Cancer Hospital), Jian Fang(Peking University), Kangsheng Gu(Anhui Medical University), Xiaorong Dong(Union Hospital), Tao Zhang(Jiangsu Hengrui Medicine (China)), Wei Shi(Jiangsu Hengrui Medicine (China)), Jianjun Zou(Jiangsu Hengrui Medicine (China))
Cited by 502
Abstract
Related Papers
No related papers found
Powered by citation graph analysis